522660-61-3
522660-61-3
Chemical Structure
SARS-CoV-2 nsp13-IN-2
- CAS No.: 522660-61-3
- Formula:C20H18N6OS2
- Molecular Weight:422.53
IUPAC Name: (E)-2-(6-((benzo[d]thiazol-2-ylthio)methyl)-4-oxo-1,4-dihydropyrimidin-2-yl)-1-(p-tolyl)guanidine
InChIKey: DNQBBFZKWCDKDV-UHFFFAOYSA-N
SMILES: CC1=CC=C(C=C1)N/C(N)=N/C2=NC(C=C(CSC3=NC4=C(S3)C=CC=C4)N2)=O
Biological Activity: SARS-CoV-2 nsp13-IN-2 (Compound C2) is a SARS-CoV-2 non-structural protein 13 (nsp13) small-molecule inhibitor with an IC50 of 42 μM against nsp13 ssDNA+ ATPase[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
SARS-CoV-2 nsp13-IN-2 | SARS-CoV-2 nsp13-IN-2 (Compound C2) is a SARS-CoV-2 non-structural protein 13 (nsp13) small-molecule inhibitor with an IC50 of 42 μM against nsp13 ssDNA+ ATPase. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
